HEADER GLUTATHIONE REDUCTASE 26-JAN-96 1XAN TITLE HUMAN GLUTATHIONE REDUCTASE IN COMPLEX WITH A XANTHENE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.6.4.2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: SG5 KEYWDS OXIDOREDUCTASE, FLAVOENZYME, GLUTATHIONE REDUCATASE, GLUTATHIONE KEYWDS 2 REDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR S.N.SAVVIDES,P.A.KARPLUS REVDAT 5 13-NOV-24 1XAN 1 REMARK REVDAT 4 05-JUN-24 1XAN 1 REMARK REVDAT 3 13-JUL-11 1XAN 1 VERSN REVDAT 2 24-FEB-09 1XAN 1 VERSN REVDAT 1 11-JUL-96 1XAN 0 JRNL AUTH S.N.SAVVIDES,P.A.KARPLUS JRNL TITL KINETICS AND CRYSTALLOGRAPHIC ANALYSIS OF HUMAN GLUTATHIONE JRNL TITL 2 REDUCTASE IN COMPLEX WITH A XANTHENE INHIBITOR. JRNL REF J.BIOL.CHEM. V. 271 8101 1996 JRNL REFN ISSN 0021-9258 JRNL PMID 8626496 JRNL DOI 10.1074/JBC.271.14.8101 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.0 REMARK 3 NUMBER OF REFLECTIONS : 33736 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.158 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3499 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 517 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 2.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1XAN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000177241. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 59.89500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.67500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 59.89500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 31.67500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 10860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -54.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 163.88085 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 72.26077 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 C9 HXP A1024 LIES ON A SPECIAL POSITION. REMARK 375 C1' HXP A1024 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 IN THE INHIBITOR-FREE CRYSTAL STRUCTURE OF HUMAN REMARK 400 GLUTATHIONE REDUCTASE (PDB ENTRY 3GRS) AN INTERSUBUNIT REMARK 400 DISULFIDE BOND OF OPTIMAL GEOMETRY IS OBSERVED BETWEEN REMARK 400 CYS 90 AND ITS CRYSTALLOGRAPHIC TWO-FOLD RELATED MATE. IN REMARK 400 THIS ENTRY, HOWEVER, THIS INTERACTION IS NOT AS OPTIMAL DUE REMARK 400 TO THE PERTURBATIONS IN THE PROTEIN STRUCTURE RESULTING REMARK 400 FROM INHIBITOR BINDING. THE ELECTRON DENSITY CORRESPONDING REMARK 400 TO THE REGION OF THE DISULFIDE BRIDGE IN QUESTION IS LESS REMARK 400 AND ELONGATED WHEN COMPARED WITH THAT OF THE INHIBITOR-FREE REMARK 400 STRUCTURE. THIS AGRESS WITH THE INCREASED MOBILITY OF THIS REMARK 400 REGION IN THE INHIBITOR-BOUND STRUCTURE AND SUGGESTS A REMARK 400 POSSIBLE DISRUPTION OF THE INTERSUBUNIT DISULFIDE BRIDGE IN REMARK 400 FRACTION OF THE MOLECULES. HYDROGEN BONDING INTERACTIONS REMARK 400 IN THIS REGION FURTHER SUPPORT A PARTIALLY OPEN REMARK 400 CONFORMATION FOR THE CYS 90 - CYS90' DISULFIDE BOND. FOR A REMARK 400 MORE EXTENSIVE DISCUSSION PLEASE CONSULT THE JRNL REMARK 400 REFERENCE. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 52 -118.86 -124.19 REMARK 500 VAL A 61 39.06 -144.41 REMARK 500 GLU A 91 -73.06 -39.70 REMARK 500 HIS A 219 -145.58 -116.51 REMARK 500 ASN A 425 175.44 63.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 499 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HXP A 1024 DBREF 1XAN A 18 478 UNP P00390 GSHR_HUMAN 18 478 SEQRES 1 A 461 VAL ALA SER TYR ASP TYR LEU VAL ILE GLY GLY GLY SER SEQRES 2 A 461 GLY GLY LEU ALA SER ALA ARG ARG ALA ALA GLU LEU GLY SEQRES 3 A 461 ALA ARG ALA ALA VAL VAL GLU SER HIS LYS LEU GLY GLY SEQRES 4 A 461 THR CYS VAL ASN VAL GLY CYS VAL PRO LYS LYS VAL MET SEQRES 5 A 461 TRP ASN THR ALA VAL HIS SER GLU PHE MET HIS ASP HIS SEQRES 6 A 461 ALA ASP TYR GLY PHE PRO SER CYS GLU GLY LYS PHE ASN SEQRES 7 A 461 TRP ARG VAL ILE LYS GLU LYS ARG ASP ALA TYR VAL SER SEQRES 8 A 461 ARG LEU ASN ALA ILE TYR GLN ASN ASN LEU THR LYS SER SEQRES 9 A 461 HIS ILE GLU ILE ILE ARG GLY HIS ALA ALA PHE THR SER SEQRES 10 A 461 ASP PRO LYS PRO THR ILE GLU VAL SER GLY LYS LYS TYR SEQRES 11 A 461 THR ALA PRO HIS ILE LEU ILE ALA THR GLY GLY MET PRO SEQRES 12 A 461 SER THR PRO HIS GLU SER GLN ILE PRO GLY ALA SER LEU SEQRES 13 A 461 GLY ILE THR SER ASP GLY PHE PHE GLN LEU GLU GLU LEU SEQRES 14 A 461 PRO GLY ARG SER VAL ILE VAL GLY ALA GLY TYR ILE ALA SEQRES 15 A 461 VAL GLU MET ALA GLY ILE LEU SER ALA LEU GLY SER LYS SEQRES 16 A 461 THR SER LEU MET ILE ARG HIS ASP LYS VAL LEU ARG SER SEQRES 17 A 461 PHE ASP SER MET ILE SER THR ASN CYS THR GLU GLU LEU SEQRES 18 A 461 GLU ASN ALA GLY VAL GLU VAL LEU LYS PHE SER GLN VAL SEQRES 19 A 461 LYS GLU VAL LYS LYS THR LEU SER GLY LEU GLU VAL SER SEQRES 20 A 461 MET VAL THR ALA VAL PRO GLY ARG LEU PRO VAL MET THR SEQRES 21 A 461 MET ILE PRO ASP VAL ASP CYS LEU LEU TRP ALA ILE GLY SEQRES 22 A 461 ARG VAL PRO ASN THR LYS ASP LEU SER LEU ASN LYS LEU SEQRES 23 A 461 GLY ILE GLN THR ASP ASP LYS GLY HIS ILE ILE VAL ASP SEQRES 24 A 461 GLU PHE GLN ASN THR ASN VAL LYS GLY ILE TYR ALA VAL SEQRES 25 A 461 GLY ASP VAL CYS GLY LYS ALA LEU LEU THR PRO VAL ALA SEQRES 26 A 461 ILE ALA ALA GLY ARG LYS LEU ALA HIS ARG LEU PHE GLU SEQRES 27 A 461 TYR LYS GLU ASP SER LYS LEU ASP TYR ASN ASN ILE PRO SEQRES 28 A 461 THR VAL VAL PHE SER HIS PRO PRO ILE GLY THR VAL GLY SEQRES 29 A 461 LEU THR GLU ASP GLU ALA ILE HIS LYS TYR GLY ILE GLU SEQRES 30 A 461 ASN VAL LYS THR TYR SER THR SER PHE THR PRO MET TYR SEQRES 31 A 461 HIS ALA VAL THR LYS ARG LYS THR LYS CYS VAL MET LYS SEQRES 32 A 461 MET VAL CYS ALA ASN LYS GLU GLU LYS VAL VAL GLY ILE SEQRES 33 A 461 HIS MET GLN GLY LEU GLY CYS ASP GLU MET LEU GLN GLY SEQRES 34 A 461 PHE ALA VAL ALA VAL LYS MET GLY ALA THR LYS ALA ASP SEQRES 35 A 461 PHE ASP ASN THR VAL ALA ILE HIS PRO THR SER SER GLU SEQRES 36 A 461 GLU LEU VAL THR LEU ARG HET FAD A 499 53 HET HXP A1024 21 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM HXP 3,6-DIHYDROXY-XANTHENE-9-PROPIONIC ACID FORMUL 2 FAD C27 H33 N9 O15 P2 FORMUL 3 HXP C16 H14 O5 FORMUL 4 HOH *517(H2 O) HELIX 1 1 SER A 30 GLU A 41 1 12 HELIX 2 2 GLY A 56 VAL A 61 1 6 HELIX 3 3 CYS A 63 ASP A 81 1 19 HELIX 4 4 ALA A 83 TYR A 85 5 3 HELIX 5 5 TRP A 96 SER A 121 1 26 HELIX 6 6 ALA A 171 LEU A 173 5 3 HELIX 7 7 SER A 177 GLN A 182 1 6 HELIX 8 8 TYR A 197 ALA A 208 1 12 HELIX 9 9 SER A 228 ASN A 240 1 13 HELIX 10 10 LYS A 296 LEU A 298 5 3 HELIX 11 11 LEU A 300 LYS A 302 5 3 HELIX 12 12 ASP A 331 CYS A 333 5 3 HELIX 13 13 THR A 339 PHE A 354 1 16 HELIX 14 14 GLU A 384 TYR A 391 1 8 HELIX 15 15 ILE A 393 ASN A 395 5 3 HELIX 16 16 MET A 406 HIS A 408 5 3 HELIX 17 17 CYS A 440 MET A 453 1 14 HELIX 18 18 LYS A 457 ASP A 461 1 5 HELIX 19 19 SER A 471 VAL A 475 5 5 SHEET 1 A 4 ALA A 19 TYR A 21 0 SHEET 2 A 4 LYS A 145 ALA A 149 1 N THR A 148 O ALA A 19 SHEET 3 A 4 THR A 139 VAL A 142 -1 N VAL A 142 O LYS A 145 SHEET 4 A 4 ALA A 130 PHE A 132 -1 N ALA A 131 O GLU A 141 SHEET 1 B 5 ILE A 326 ALA A 328 0 SHEET 2 B 5 HIS A 151 ILE A 154 1 N ILE A 152 O TYR A 327 SHEET 3 B 5 TYR A 23 ILE A 26 1 N LEU A 24 O HIS A 151 SHEET 4 B 5 ALA A 46 GLU A 50 1 N ALA A 47 O TYR A 23 SHEET 5 B 5 GLU A 124 ARG A 127 1 N GLU A 124 O VAL A 48 SHEET 1 C 2 GLY A 158 PRO A 160 0 SHEET 2 C 2 ARG A 291 PRO A 293 -1 N VAL A 292 O MET A 159 SHEET 1 D 4 CYS A 284 TRP A 287 0 SHEET 2 D 4 ARG A 189 VAL A 193 1 N VAL A 191 O CYS A 284 SHEET 3 D 4 LYS A 212 MET A 216 1 N LYS A 212 O SER A 190 SHEET 4 D 4 GLU A 244 LEU A 246 1 N GLU A 244 O LEU A 215 SHEET 1 E 3 VAL A 275 ILE A 279 0 SHEET 2 E 3 GLY A 260 THR A 267 -1 N THR A 267 O VAL A 275 SHEET 3 E 3 SER A 249 THR A 257 -1 N THR A 257 O GLY A 260 SHEET 1 F 5 PRO A 368 VAL A 371 0 SHEET 2 F 5 ILE A 377 GLY A 381 -1 N THR A 379 O THR A 369 SHEET 3 F 5 LYS A 429 GLN A 436 -1 N MET A 435 O GLY A 378 SHEET 4 F 5 CYS A 417 ALA A 424 -1 N ALA A 424 O LYS A 429 SHEET 5 F 5 VAL A 396 PHE A 403 -1 N PHE A 403 O CYS A 417 SSBOND 1 CYS A 58 CYS A 63 1555 1555 2.05 SSBOND 2 CYS A 90 CYS A 90 1555 2656 2.16 CISPEP 1 HIS A 374 PRO A 375 0 -7.21 CISPEP 2 HIS A 467 PRO A 468 0 -7.13 SITE 1 AC1 39 GLY A 27 GLY A 29 SER A 30 GLY A 31 SITE 2 AC1 39 VAL A 49 GLU A 50 SER A 51 HIS A 52 SITE 3 AC1 39 GLY A 56 THR A 57 CYS A 58 GLY A 62 SITE 4 AC1 39 CYS A 63 LYS A 66 GLY A 128 HIS A 129 SITE 5 AC1 39 ALA A 130 ALA A 155 THR A 156 GLY A 157 SITE 6 AC1 39 TYR A 197 ARG A 291 LEU A 298 GLY A 330 SITE 7 AC1 39 ASP A 331 LEU A 337 LEU A 338 THR A 339 SITE 8 AC1 39 PRO A 340 HIS A 467 PRO A 468 HOH A 502 SITE 9 AC1 39 HOH A 504 HOH A 510 HOH A 515 HOH A 554 SITE 10 AC1 39 HOH A 826 HOH A 859 HOH A 864 SITE 1 AC2 8 ASN A 71 VAL A 74 HIS A 75 PHE A 78 SITE 2 AC2 8 HIS A 82 TYR A 407 HOH A 561 HOH A 820 CRYST1 119.790 63.350 84.650 90.00 58.61 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008348 0.000000 -0.005094 0.00000 SCALE2 0.000000 0.015785 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013839 0.00000